Pharmala Biotech Holdings Inc. (CSE:MDMA)

Market Cap	10.04M
Revenue	n/a
Net Income	n/a
Shares Out	105.68M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	511,857
Average Volume	282,349
Open	0.0950
Previous Close	0.0900
Day's Range	0.0900 - 0.1000
52-Week Range	0.0650 - 0.3400
Beta	1.39
RSI	25.75
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA